Clinical Trial Update: Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

Open-label Phase 3 study evaluating the safety of multiple courses of IM alefacept in chronic plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Amevive (alefacept)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Psoriasis | Phase 3 | Status: COMPLETED